Found 20 matching trials
Immunogenicity and Safety of the 9-valent Human Papillomavirus (9vHPV) Vaccine in Japanese Boys and Girls (V503-066) PHASE3 The primary objective of this study is the estimation of the human papillom...
Show More Location
Sotobo Children's Clinic ( Site 6616)
Learn More & Join Trial
Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED) PHASE3 This is an immunogenicity and safety study of Gardasil (V501) in females 9 ...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia PHASE2 Background:
Diseases related to human papillomavirus (HPV) include warts, ...
Show More Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Immunogenicity and Tolerability of V503 Versus GARDASIL (V503-009) PHASE3 Primary objective:
⢠To demonstrate that administration of V503 induces no...
Show More Location
Multiple Locations
Learn More & Join Trial
HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini PHASE4 This is a multi-site, open-label non-inferiority study of the 9vHPV vaccine...
Show More Learn More & Join Trial
Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053) PHASE3 This study is designed to demonstrate non-inferior immunogenicity of 3 dose...
Show More Status
Active Not Recruiting
Location
Liucheng County Centers for Disease Control and Prevention ( Site 0005)
Learn More & Join Trial
Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old EARLY_PHASE1 This study is an open-label nonrandomized exploratory proof of concept and ...
Show More Status
Active Not Recruiting
Location
Boston Medical Center
Learn More & Join Trial
A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men (V503-020) PHASE3 Primary objective
To demonstrate that administration of V503 induces non-i...
Show More Location
Sanofi Pasteur MSD Investigational Site 1002
Learn More & Join Trial
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076) PHASE3 The purpose of this study to evaluate the safety and immunogenicity of a 2-...
Show More Location
Cognitive Clinical Trials, LLC ( Site 0054)
Learn More & Join Trial
HPV Vaccine Immunity in High-risk Women PHASE4 This is a single arm immunological study based in Vietnam. The study will e...
Show More Location
Hai Phong District Health Centre
Learn More & Join Trial